SCHRODER INVESTMENT MANAGEMENT GROUP - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,071,724
-84.8%
52,076
-65.4%
0.00%
-80.0%
Q2 2023$7,067,294
+212.3%
150,304
+178.7%
0.01%
+233.3%
Q1 2023$2,262,735
+3.4%
53,926
-6.0%
0.00%0.0%
Q4 2022$2,188,702
+36378.4%
57,386
+40030.1%
0.00%
Q4 2021$6,000
+50.0%
143
+70.2%
0.00%
Q3 2021$4,000
-20.0%
840.0%0.00%
Q2 2021$5,000
-99.8%
84
-99.7%
0.00%
-100.0%
Q1 2021$2,275,000
-83.8%
30,399
-81.3%
0.00%
-70.0%
Q4 2020$14,086,000
+220.9%
162,830
+116.6%
0.01%
+42.9%
Q3 2020$4,390,000
+74.3%
75,164
+24.1%
0.01%
+40.0%
Q2 2020$2,518,000
+312.8%
60,553
+181.5%
0.01%
+400.0%
Q1 2020$610,000
+244.6%
21,508
+1635.9%
0.00%
Q3 2019$177,000
+15.7%
1,239
+48.0%
0.00%
Q2 2019$153,000
-52.3%
837
-58.6%
0.00%
-100.0%
Q1 2019$321,000
+26.4%
2,020
-23.8%
0.00%
Q4 2018$254,000
-35.9%
2,650
-5.4%
0.00%
-100.0%
Q3 2018$396,000
+9.7%
2,801
+17.9%
0.00%0.0%
Q2 2018$361,0002,3750.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders